RNAscope™ assay is a proprietary RNA in situ hybridization (ISH) assay based on ACD patented signal amplification and background suppression technology which advances RNA biomarker analysis in tissues and cells.

Using RNAscope™ assay you can:

• Detect single RNA molecule at single-cell resolution in a single-day
• Asses splice variants, highly homologous sequences, lncRNA, and targets lacking IHC antibodies
• Analyze tumor heterogeneity using Dual ISH-IHC and Multiplex assays

This enables researchers to visualize genes that are expressed, localize where they are expressed in any complex tissue from any species. The RNAscope™ technology is proven and published in over 900 publications in various research areas such as neuroscience, immuno-oncology, infectious disease and stem cell. This technology is commonly used for dual ISH-IHC analysis, RNA-Seq validation, single-cell analysis, and recently introduced BaseScope™ assay makes detection of exon junctions and highly homologous targets also possible.

Presentations:

• Visualizing Lrit1 and Lrit3 in the mouse retina using RNAScope^® in situ hybridization.
  Alexander Chamessian, School of Medicine, Duke University
   
• Current state-of-the-art tissue-based RNA analysis with RNAscope™ Technology 
  Jordan Brown, Advanced Cell Diagnostics, Inc.

Join this seminar to learn how RNAscope™ Technology has been used in different research areas.